The impact of the ‘Better Care Better Value’ prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimental design

BACKGROUND: In April/2009, the UK National Health Service initiated four Better Care Better Value (BCBV) prescribing indicators, one of which encouraged the prescribing of cheaper angiotensin-converting enzyme inhibitors (ACEIs) instead of expensive angiotensin receptor blockers (ARBs), with 80 % AC...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Amanj, Chen, Li-Chia, Elliott, Rachel A., Godman, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566432/
https://www.ncbi.nlm.nih.gov/pubmed/26359265
http://dx.doi.org/10.1186/s12913-015-1013-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566432/
https://www.ncbi.nlm.nih.gov/pubmed/26359265
http://dx.doi.org/10.1186/s12913-015-1013-y

Ejemplares similares